Literature DB >> 20129751

Elution behavior of insulin on high-performance size exclusion chromatography at neutral pH.

Ruedeeporn Tantipolphan1, Stefan Romeijn, John den Engelsman, Riccardo Torosantucci, Tue Rasmussen, Wim Jiskoot.   

Abstract

The pharmacopoeia protocol for HP-SEC of insulin, using an acidic non-physiological eluent, does not represent insulin's association state in the formulation. This study aimed to evaluate insulin's elution behavior in HP-SEC in a "physiological" (aqueous, neutral pH) eluent, using on-line UV absorption and multi-angle laser light scattering detection. The effect of insulin concentration and association state in the formulation (monitored by circular dichroism) and eluent composition (zinc ion, arginine) on its elution behavior was assessed. We showed that the elution behavior of insulin in "physiological" HP-SEC is affected by both dynamic association-dissociation of insulin molecules and insulin-column interactions. Insulin molecules re-equilibrated in the HP-SEC eluent, making its elution behavior practically insensitive to the association state of insulin in the formulation. Zinc ions in the eluent promoted association of insulin to hexamers, whereas arginine overruled the effect of zinc ions and induced on-column dissociation of insulin to dimers and monomers. Combined results from "physiological" and compendial HP-SEC were shown to provide a better view of the aggregation state of heat-stressed insulin than either of the single methods. The insights obtained with this study are crucial for a proper evaluation of HP-SEC data of insulin. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129751     DOI: 10.1016/j.jpba.2010.01.014

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

Review 1.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

Review 2.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

3.  ICA512 RESP18 homology domain is a protein-condensing factor and insulin fibrillation inhibitor.

Authors:  Pamela L Toledo; Juha M Torkko; Andreas Müller; Carolin Wegbrod; Anke Sönmez; Michele Solimena; Mario R Ermácora
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

4.  Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.

Authors:  Christian Fogt Hjorth; František Hubálek; Jonatan Andersson; Christian Poulsen; Daniel Otzen; Helle Naver
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

5.  Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

Authors:  Indu Javeri; Kaliappanadar Nellaiappan; Charles McNemar; Kirill Yakovlevsky; Amina Soukrati; Phanindra Velisetty; Bijay Misra
Journal:  Pharm Res       Date:  2018-06-26       Impact factor: 4.200

6.  Insight into human insulin aggregation revisited using NMR derived translational diffusion parameters.

Authors:  Jerzy Sitkowski; Wojciech Bocian; Elżbieta Bednarek; Mateusz Urbańczyk; Wiktor Koźmiński; Piotr Borowicz; Grażyna Płucienniczak; Natalia Łukasiewicz; Iwona Sokołowska; Lech Kozerski
Journal:  J Biomol NMR       Date:  2018-06-12       Impact factor: 2.835

7.  Characterization of DNA nanostructure stability by size exclusion chromatography.

Authors:  Nicole I Langlois; Heather A Clark
Journal:  Anal Methods       Date:  2022-03-10       Impact factor: 3.532

8.  Chemical modifications in aggregates of recombinant human insulin induced by metal-catalyzed oxidation: covalent cross-linking via michael addition to tyrosine oxidation products.

Authors:  Riccardo Torosantucci; Olivier Mozziconacci; Victor Sharov; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2012-05-10       Impact factor: 4.200

9.  Heat-stability study of various insulin types in tropical temperature conditions: New insights towards improving diabetes care.

Authors:  Beatrice Kaufmann; Philippa Boulle; Flavien Berthou; Margot Fournier; David Beran; Iza Ciglenecki; Malcolm Townsend; Guillaume Schmidt; Maya Shah; Susanna Cristofani; Philippe Cavailler; Michelangelo Foti; Leonardo Scapozza
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

10.  Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates.

Authors:  Paula Hong; Stephan Koza; Edouard S P Bouvier
Journal:  J Liq Chromatogr Relat Technol       Date:  2012-11-30       Impact factor: 1.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.